natgillin/translations-raw huggingface dataset:
‘They shall apply those provisions from 5 April 2013. However, they shall apply the provisions necessary to comply with Article 3(6) and Articles 13 and 14 from 5 April 2015.’;
„Navedene predpise uporabljajo od 5. aprila 2013. Določbe, potrebne za skladnost s členom 3(6) ter členoma 13 in 14, pa uporabljajo od 5. aprila 2015.“
the following Article 15a is inserted:
Vstavi se naslednji člen 15a:
By 31 December 2020, the Commission shall carry out a review to assess whether technical progress has made it possible to revoke the exemptions set out in point 3 of the Annex.’;
Komisija do 31. decembra 2020 opravi pregled, da se oceni, ali tehnični napredek omogoča preklic izjem iz točke 3 Priloge.“
in point 3 of the Annex, the following paragraphs are added:
V točki 3 Priloge se dodajo naslednji odstavki:
‘For articles too small to affix the information under point 1(b)(i) and (ii) and point 2 or where it is technically impossible due to their shape or design to affix a unique identification, a unique identification shall be affixed on each smallest packaging unit.
„Pri izdelkih, ki so premajhni za namestitev informacij iz točk 1(b)(i), 1(b)(ii) in 2, ter izdelkih, pri katerih namestitev identifikacijske oznake tehnično ni mogoča zaradi njihove oblike ali zasnove, se identifikacijska oznaka namesti na vsako najmanjšo enoto embalaže.
Each smallest packaging unit shall be closed with a seal.
Vsaka najmanjša enota embalaže mora biti zapečatena.
Each plain detonator or booster falling under the exemption set out in the second paragraph shall be marked in a durable way so as to ensure that it is clearly legible with the information under point 1(b)(i) and (ii).
Vse vžigalne kapice ali ojačevalci eksplozije, za katere se uporablja izjema iz drugega odstavka, se trajno in lahko berljivo označijo z informacijami iz točk 1(b)(i) in 1(b)(ii).
The number of plain detonators and boosters contained shall be printed on the smallest packaging unit.
Na najmanjši enoti embalaže se navede število vsebovanih vžigalnih kapic in ojačevalcev eksplozije.
Each detonating cord falling under the exemption set out in the second paragraph shall be marked with the unique identification on the reel or spool and, where applicable, on the smallest packaging unit.’.
Vse detonacijske vrvice, za katere se uporablja izjema iz drugega odstavka, se označijo z identifikacijsko oznako na motku ali tuljavi ter, kadar je ustrezno, na najmanjši enoti embalaže.“
Member States shall adopt and publish, by 4 April 2012 at the latest, the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice najpozneje do 4. aprila 2012 sprejmejo in objavijo zakone ter druge predpise in določbe, potrebne za uskladitev s to direktivo.
They shall forthwith communicate to the Commission the text of those provisions and a correlation table between those provisions and this Directive.
Komisiji nemudoma sporočijo besedilo navedenih predpisov ter korelacijsko tabelo med navedenimi predpisi in to direktivo.
They shall apply those provisions from 5 April 2013.
Navedene predpise uporabljajo od 5. aprila 2013.
This Directive shall enter into force on the 20th day following its publication in the Official Journal of the European Union.
Ta direktiva začne veljati [dvajseti] dan po objavi v Uradnem listu Evropske unije.
In order to allow this, the obligation on manufacturers and importers to mark explosives should be postponed by 1 year to 5 April 2013.
V ta namen je treba obveznost proizvajalcev in uvoznikov o označevanju eksplozivov odložiti za eno leto, do 5. aprila 2013.
Additional time is necessary to have the requisite electronic tracking systems implemented by all actors along the supply chain.
Potreben je dodaten čas, da bodo predpisane sisteme elektronskega sledenja lahko začeli uporabljati vsi akterji v dobavni verigi.
The unique identification will be marked every 5 meters on either the external envelope of the cord or the plastic extruded inner layer immediately under the exterior fibre of the cord. An associated label shall be placed on each case of detonating cord. In addition, undertakings may use a passive inert electronic tag inserted within the cord, and an associated tag for each case of cord.’;
Poleg tega lahko podjetja uporabijo pasivno inertno elektronsko tablico, vstavljeno v detonacijsko vrvico, in pripadajočo tablico za vsako kaseto detonacijske vrvice.“
Directive 2012/5/EU of the European Parliament and of the Council
Direktiva 2012/5/EU Evropskega parlamenta in Sveta
amending Council Directive 2000/75/EC as regards vaccination against bluetongue
o spremembah Direktive Sveta 2000/75/ES, glede cepljenja proti bolezni modrikastega jezika
Council Directive 2000/75/EC of 20 November 2000 laying down specific provisions for the control and eradication of bluetongue [3] lays down control rules and measures to combat and eradicate bluetongue, including rules on the establishment of protection and surveillance zones and the use of vaccines against bluetongue.
Direktiva Sveta 2000/75/ES z dne 20. novembra 2000 o določitvi posebnih določb za boj zoper in izkoreninjenje bolezni modrikastega jezika [3] določa pravila in ukrepe nadzora za boj zoper bolezen modrikastega jezika in njeno izkoreninjenje, vključno s pravili o vzpostavitvi okuženih in ogroženih območij ter uporabi cepiv proti bolezni modrikastega jezika.
In the past, only sporadic incursions of certain serotypes of the bluetongue virus were recorded in the Union.
V preteklosti so bili v Uniji evidentirani le občasni vdori nekaterih serotipov virusa bolezni modrikastega jezika.
Those incursions mainly occurred in the southern parts of the Union.
Ti vdori so se pojavili predvsem v južnih delih Unije.
However, since the adoption of Directive 2000/75/EC, and particularly since the introduction into the Union of bluetongue virus serotypes 1 and 8 in the years 2006 and 2007, the bluetongue virus has become more widespread in the Union, with the potential to become endemic in certain areas.
Vendar pa je po sprejetju Direktive 2000/75/ES in zlasti po pojavu serotipov 1 in 8 virusa bolezni modrikastega jezika v letih 2006 in 2007 virus bolezni modrikastega jezika postal bolj široko razširjen v Uniji z možnostjo, da na določenih območjih postane endemičen.
It has therefore become difficult to control the spread of that virus.
Zato je postalo težko nadzirati širitev navedenega virusa.
The rules on vaccination against bluetongue laid down in Directive 2000/75/EC are based on experience of the use of so-called ‘modified live vaccines’, or ‘live attenuated vaccines’, which were the only vaccines available when that Directive was adopted.
Pravila o cepljenju proti bolezni modrikastega jezika, kot so določena v Direktivi 2000/75/ES, temeljijo na izkušnjah z uporabo tako imenovanih „modificiranih živih cepiv“ ali „oslabljenih živih cepiv“, ki so bila v času sprejetja navedene direktive edina razpoložljiva cepiva.
The use of those vaccines may lead to an undesired local circulation of the vaccine virus in unvaccinated animals.
Uporaba teh cepiv lahko pripelje do nezaželenega lokalnega kroženja cepilnega virusa med necepljenimi živalmi.
In recent years, as a result of new technology, ‘inactivated vaccines’ against bluetongue have become available which do not pose the risk of undesired local circulation of the vaccine virus to unvaccinated animals.
V zadnjih letih so kot posledica nove tehnologije postala na voljo „inaktivirana cepiva“ proti bolezni modrikastega jezika, ki ne pomenijo tveganja nezaželenega lokalnega kroženja cepilnega virusa med necepljenimi živalmi.
The extensive use of such vaccines during the vaccination campaign in the years 2008 and 2009 has led to a significant improvement in the disease situation.
S široko uporabo takih cepiv med akcijo cepljenja v letih 2008 in 2009 se je stanje glede bolezni znatno izboljšalo.
It is now widely accepted that vaccination with inactivated vaccines is the preferred tool for the control of bluetongue and for the prevention of clinical disease in the Union.
Splošno sprejeto je, da je cepljenje z inaktiviranimi cepivi najprimernejše orodje za nadzor bolezni modrikastega jezika in preprečevanje klinične bolezni v Uniji.
In order to ensure better control of the spread of the bluetongue virus and to reduce the burden on the agricultural sector posed by that disease, it is appropriate to amend the current rules on vaccination laid down in Directive 2000/75/EC in order to take account of the recent technological developments in vaccine production.
Za zagotovitev boljšega nadzora bolezni modrikastega jezika in zmanjšanja bremena, ki ga kmetijskemu sektorju povzroča navedena bolezen, je primerno spremeniti trenutna pravila o cepljenju iz Direktive 2000/75/ES, da se upošteva najnovejši tehnološki razvoj pri proizvodnji cepiv.
In order to enable the vaccination season 2012 to benefit from the new rules, this Directive should enter into force on the day following its publication in the Official Journal of the European Union.
Da bi novi predpisi veljali za cepljenje v letu 2012, bi morala ta direktiva začeti veljati dan po objavi v Uradnem listu Evropske unije.
The amendments provided for in this Directive should make the rules on vaccination more flexible and also take into account the fact that inactivated vaccines that can also be successfully used outside areas subject to animal movement restrictions are now available.
S spremembami v tej direktive bi bilo treba pravila o cepljenju narediti prožnejša in obenem upoštevati dejstvo, da so zdaj na voljo inaktivirana cepiva, ki se lahko uspešno uporabljajo tudi zunaj območij, za katera veljajo omejitve gibanja živali.
In addition, and provided that appropriate precautionary measures are taken, the use of live attenuated vaccines should not be excluded, as their use might still be necessary under certain circumstances, such as following the introduction of a new bluetongue virus serotype against which inactivated vaccines may not be available.
Poleg tega uporaba oslabljenih živih cepiv ne bi smela biti izvzeta, če se uvedejo ustrezni varnostni ukrepi, saj bi ta lahko bila še vedno potrebna v določenih razmerah, kot na primer po pojavu novega serotipa virusa bolezni modrikastega jezika, proti kateremu inaktivirana cepiva morda še ne bodo na voljo.
Directive 2000/75/EC should therefore be amended accordingly,
Zato bi bilo treba Direktivo 2000/75/ES ustrezno spremeniti –
Directive 2000/75/EC is hereby amended as follows:
Direktiva 2000/75/ES se spremeni, kot sledi:
in Article 2, the following point is added:
v členu 2 se doda naslednja točka:
“live attenuated vaccines”
„oslabljena živa cepiva“
vaccines which are produced by adapting bluetongue virus field isolates through serial passages in tissue culture or in embryonated hens’ eggs.’;
cepiva, ki so proizvedena s prilagoditvijo v naravi prisotnih izolatov virusa bolezni modrikastega jezika z zaporednimi pasažami na tkivnih kulturah ali na oplojenih kokošjih jajcih.“;
The competent authority of a Member State may decide to allow the use of vaccines against bluetongue provided that:
Pristojni organ države članice lahko dovoli uporabo cepiva proti bolezni modrikastega jezika, če:
such decision is based on the result of a specific risk assessment carried out by the competent authority;
taka odločitev temelji na rezultatih posebne ocene tveganja, ki jo je izvedel pristojni organ;
the Commission is informed before such vaccination is carried out.
je Komisija obveščena pred izvajanjem takega cepljenja.
Whenever live attenuated vaccines are used, Member States shall ensure that the competent authority demarcates:
Kadar koli se uporabijo oslabljena živa cepiva, države članice zagotovijo, da pristojni organ določi meje:
a protection zone, consisting of at least the vaccination area;
okuženega območja, ki vključuje vsaj območje cepljenja;
a surveillance zone, consisting of a part of the Union territory with a depth of at least 50 kilometres extending beyond the limits of the protection zone.’;
ogroženega območja, ki vključuje del ozemlja Unije in sega najmanj 50 kilometrov čez meje okuženega območja.“;
in Article 6(1), point (d) is replaced by the following:
v členu 6(1) se točka (d) nadomesti z naslednjim:
implement the measures adopted in accordance with the procedure laid down in Article 20(2), in particular with regard to the introduction of any vaccination programme or other alternative measures;’;
izvaja ukrepe, sprejete v skladu s postopkom iz člena 20(2), še zlasti v zvezi z uvedbo kakršnega koli programa cepljenja ali drugih alternativnih ukrepov;“;
in Article 8(2), point (b) is replaced by the following:
v členu 8(2) se točka (b) nadomesti z naslednjim:
The surveillance zone shall consist of a part of the Union territory with a depth of at least 50 kilometres extending beyond the limits of the protection zone and in which no vaccination against bluetongue with live attenuated vaccines has been carried out during the previous 12 months.’;
Ogroženo območje obsega del ozemlja Unije, ki sega najmanj 50 kilometrov čez meje okuženega območja in na katerem ni bilo v preteklih 12 mesecih opravljeno nikakršno cepljenje proti bolezni modrikastega jezika z oslabljenimi živimi cepivi.“;
in Article 10, point 2 is replaced by the following:
v členu 10 se točka 2 nadomesti z naslednjim:
any vaccination against bluetongue using live attenuated vaccines is prohibited in the surveillance zone.’.
je na ogroženem območju prepovedano kakršno koli cepljenje proti bolezni modrikastega jezika z oslabljenimi živimi cepivi.“
Member States shall adopt and publish, by 23 September 2012 at the latest, the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice sprejmejo in objavijo zakone in druge predpise za uskladitev s to direktivo najpozneje do 23. septembra 2012.
They shall communicate immediately to the Commission the text of those provisions.
Komisijo nemudoma obvestijo o besedilih zadevnih določb teh predpisov.
They shall apply those provisions from 24 September 2012 at the latest.
Te predpise začnejo uporabljati najpozneje od 24. septembra 2012.
Member States shall communicate to the Commission the text of the main provisions of national law which they adopt in the field covered by this Directive.
Države članice Komisijo obvestijo o besedilih zadevnih določb predpisov nacionalnega prava, sprejetih na področju, ki ga ureja ta direktiva.
OJ C 132, 3.5.2011, p. 92.
UL C 132, 3.5.2011, str. 92.
Position of the European Parliament of 7 April 2011 (not yet published in the Official Journal) and position of the Council at first reading of 15 December 2011 (OJ C 46 E, 17.2.2012, p. 15).
Stališče Evropskega parlamenta z dne 7. aprila 2011 (še ni objavljeno v Uradnem listu) in stališče Sveta v prvi obravnavi z dne 15. decembra 2011 (UL C 46 E, 17.2.2012, str. 15).
Position of the European Parliament of 14 February 2012 (not yet published in the Official Journal).
Stališče Evropskega parlamenta z dne 14. februarja 2012 (še ni objavljeno v Uradnem listu).
Directive 2012/6/EU of the European Parliament and of the Council
Direktiva 2012/6/EU Evropskega parlamenta in Sveta
amending Council Directive 78/660/EEC on the annual accounts of certain types of companies as regards micro-entities
o spremembah Direktive Sveta 78/660/EGS o letnih računovodskih izkazih posameznih vrst družb, v zvezi z mikrosubjekti
Having regard to the Treaty on the Functioning of the European Union, and in particular Article 50(1) thereof,
ob upoštevanju Pogodbe o delovanju Evropske unije, zlasti člena 50(1) Pogodbe,
The European Council of 8 and 9 March 2007 underlined in its conclusions that reducing administrative burdens is important for boosting Europe's economy and that a strong joint effort to reduce administrative burdens within the European Union is necessary.
(1) Evropski svet je v svojih sklepih z zasedanj dne 8. in 9. marca 2007 poudaril, da je zmanjšanje upravne obremenitve pomembno za spodbujanje evropskega gospodarstva in da si je treba za zmanjšanje upravnih obremenitev v Evropski uniji odločno prizadevati skupaj.
Accounting has been identified as one of the key areas in which administrative burdens for companies within the Union may be reduced.
Računovodstvo je bilo opredeljeno kot eno od ključnih področij, na katerem se lahko zmanjša upravna obremenitev podjetij v Uniji.
Commission Recommendation 2003/361/EC [3] defines micro, small and medium-sized enterprises.
Priporočilo Komisije 2003/361/ES [3] opredeljuje mikro-, mala in srednja podjetja.
However, consultations with Member States have indicated that the size criteria for micro-enterprises in that Recommendation may be too high for accounting purposes.
Vendar so posvetovanja z državami članicami pokazala, da so merila glede velikosti za mikropodjetja v navedenem priporočilu za računovodske namene morda previsoka.
Therefore, a sub-group of micro-enterprises, so-called "micro-entities", should be introduced to cover companies with lower size criteria for balance sheet total and net turnover than those laid down for micro-enterprises.
Zato bi bilo treba uvesti podskupino mikropodjetij, tako imenovane „mikrosubjekte“, ki bi vključevala družbe z nižjimi merili glede velikosti bilančne vsote in čistih prihodkov od prodaje, kot so določene za mikropodjetja.
Micro-entities are in most cases engaged in business at local or regional level with no or limited cross-border activity.
Mikrosubjekti večinoma poslujejo lokalno ali regionalno, njihova čezmejna dejavnost je skromna ali pa je sploh ni.
In addition, they play an important role in creating new jobs, fostering research and development and creating new economic activities.
Poleg tega imajo pomembno vlogo pri ustvarjanju novih delovnih mest, spodbujanju raziskav in razvoja ter ustvarjanju novih gospodarskih dejavnosti.
Micro-entities have limited resources with which to comply with demanding regulatory requirements.
Mikrosubjekti nimajo veliko sredstev za izpolnjevanje strogih zakonskih predpisov.
However, they are often subject to the same financial reporting rules as larger companies.
Vendar pa zanje pogosto veljajo ista pravila o finančnemu poročanju kot za večje družbe.
Those rules place on them a burden which is not in proportion to their size and is therefore disproportionate for the smallest enterprises as compared to larger ones.
Ta pravila ustvarjajo breme, ki ni sorazmerno z njihovo velikostjo in je torej za najmanjša podjetja nesorazmerno v primerjavi z večjimi.
Therefore, it should be possible to exempt micro-entities from certain obligations that may impose on them an unnecessarily onerous administrative burden.
Zato bi moralo biti možno mikrosubjekte oprostiti določenih obveznosti, ki bi jim lahko naložile nepotrebno upravno obremenitev.
However, micro-entities should still be subject to any national obligation to keep records showing their business transactions and financial position.
Vseeno pa bi morale za mikrosubjekte še naprej veljati vse nacionalne obveznosti vodenja evidence poslovnih transakcij in finančnega stanja.
Given that the numbers of companies to which the size criteria set in this Directive will apply will vary greatly from one Member State to another, and given that the activities of micro-entities have no bearing, or only a limited bearing, on cross-border trade or the functioning of the internal market, Member States should take into account the differing impact of those criteria when implementing this Directive at national level.
Ker se bo število družb, za katere bodo veljala merila glede velikosti iz te direktive, med posameznimi državami članicami zelo razlikovalo in ker dejavnosti mikrosubjektov zelo malo ali sploh ne vplivajo na čezmejno trgovino ali delovanje notranjega trga, bi morale države članice različne učinke teh meril upoštevati pri izvajanju te direktive na nacionalni ravni.
Member States should take into account the specific conditions and needs of their own markets when making decisions about how or whether to implement a micro-entity regime within the context of Council Directive 78/660/EEC [4].
Države članice bi morale pri odločanju o tem, kako in ali bodo sploh uveljavile ureditev za mikrosubjekte v okviru Direktive Sveta 78/660/EGS [4], upoštevati konkreten položaj in potrebe svojih trgov.
Micro-entities must take account of income and charges relating to the financial year, irrespective of the date of receipt or payment of such income or charges.
Mikrosubjekti morajo upoštevati prihodke in stroške v poslovnem letu, ne glede na datum prejema ali plačila takšnih prihodkov ali stroškov.
However, the calculation of prepayments and accrued income and accruals and deferred income can be burdensome for micro-entities.
Toda zanje je lahko izračunavanje aktivnih in pasivnih časovnih razmejitev obremenjujoče.
Consequently, Member States should be permitted to exempt micro-entities from calculating and presenting such items, only to the extent that such exemption relates to charges other than the cost of raw materials and consumables, value adjustments, staff costs and tax.
Državam članicam bi zato moralo biti dovoljeno, da mikrosubjekte oprostijo obveznosti izračunavanja in poročanja o takšnih postavkah samo, v kolikor se taka oprostitev nanaša na stroške, ki niso stroški surovin in potrošnega materiala, popravki vrednosti, stroški za osebje in davki.
In this way, the administrative burden involved in calculating relatively small balances may be reduced.
Na ta način se lahko upravno breme, povezano z izračunavanjem razmeroma majhne bilančne vsote, zmanjša.
Publication of annual accounts can be burdensome for micro-entities.
Objavljanje letnih računovodskih izkazov je lahko za mikrosubjekte obremenjujoče.
At the same time, Member States need to ensure compliance with this Directive.
Toda države članice morajo zagotoviti skladnost s to direktivo.
Accordingly, Member States should be permitted to exempt micro-entities from a general publication requirement, provided that balance sheet information is duly filed, in accordance with national law, with at least one designated competent authority and that the information is transmitted to the business register, so that a copy should be obtainable upon application.
Zato bi bilo treba državam članicam dovoliti, da mikrosubjekte oprostijo splošne obveznosti objavljanja, če se podatki o bilanci stanja sporočijo vsaj enemu imenovanemu pristojnemu organu v skladu z nacionalnim pravom in se predložijo poslovnemu registru, tako da je na zahtevo mogoče pridobiti en izvod.
In such cases the obligation laid down in Article 47 of Directive 78/660/EEC to publish any accounting document in accordance with Article 3(5) of Directive 2009/101/EC [5], would not apply.
V takih primerih ne bi veljala obveznost iz člena 47 Direktive 78/660/EGS, da se računovodske listine objavijo v skladu s členom 3(5) Direktive 2009/101/ES [5].
The aim of this Directive is to enable Member States to create a simple financial reporting environment for micro-entities.
Namen te direktive je državam članicam omogočiti, da za mikrosubjekte ustvarijo preprosto okolje finančnega poročanja.
The use of fair values can result in the need for detailed disclosures to explain the basis on which the fair value of certain items has been determined.
Če bi se uporabilo pošteno vrednotenje, bi bilo morda treba podlago, na kateri je bila ocenjena poštena vrednost nekaterih postavk, utemeljevati s podrobnimi podatki.
Given that the micro-entity regime provides for very limited disclosure by way of notes on the accounts, the users of the accounts of micro-entities would not know whether the amounts presented in the balance sheet and the profit and loss account incorporate fair values.
Glede na to, da je v ureditvi za mikrosubjekte predvideno zelo omejeno razkritje v obliki pojasnil k računovodskim izkazom, uporabniki izkazov mikrosubjektov ne bi vedeli, ali navedeni zneski iz bilance stanja in izkaza poslovnega izida predstavljajo poštene vrednosti.